Well, sort of. Here is what I mean:
- Stanford created a broad multi-disciplinary group of 90+ scientists dedicated to making the treatment of the inner ear as accessible as the middle ear.
This is a positive development organizationally, but it is not actual scientific progress.
- Contrary to old medical belief, the human inner ear does have some (limited) natural hair cell regeneration capabilities. A potential treatment would be able to amplify this regeneration process via gene therapy. A specific gene in rodents has been identified that is responsible for their hair cell regeneration.
Was the gene in rodents identified at Stanford, or by this group? Or was the discovery made elsewhere?
- Currently, studies on cells in the inner ear are done almost exclusively in cells that have been removed from the cochlea. New imaging technology will allow scientists to study these cells in-vivo.
This describes something that "will happen," so it does not represent actual progress thus far.
- The problem of delivering drugs to the cochlea past a wall of bone is making progress, scientists are now able to use microsurgery to dissolve small sections of the inner ear bones in rodents to create a window to the cochlea, with no adverse effects on the hearing of the rodent.
Was this progress made at Stanford, or by this group? Or was the progress made elsewhere?
- Deep Brain Stimulation therapy has gotten much more specific and is a promising way to suppress tinnitus that the team is studying in addition to hair cell regeneration.
I'm glad the team is studying this. Have they found anything yet?
From what is said here, it certainly sounds like there is the potential for Stanford to make progress in the future. But I am curious to hear what progress Stanford has made thus far, beyond forming the group and making plans, given that this thread is 5 years old.